Table 1 Clinical characteristics of the patients included in the study
From: Benefits of an early cooling phase in continuous renal replacement therapy for ICU patients
Total n = 30 | Group A n = 16 | Group B n = 14 | |
|---|---|---|---|
Age (yr) | 66.5 [10.3] | 68.3 [12.3] | 65.2 [7.3] |
Sex male (no.patients) | 21 | 12 | 9 |
SAPS 2 on admission | 55.0 [14.1] | 60.5 [12.0] | 50.0 [13.9] |
SOFA on admission | 10.6 [4.6] | 12.8 [3.8] | 8.0 [3.8] |
Main diagnosis (no. patients) | |||
Severe sepsis | 20 | 12 | 8 |
Abdominal | 7 | 6 | 1 |
Pneumonia | 6 | 2 | 4 |
Miscellaneous | 7 | 4 | 3 |
Cardiac surgery | 4 | 1 | 3 |
Respiratory failure | 2 | 1 | 1 |
Mesenteric ischemia | 2 | 1 | 1 |
Temperature (°C) at ICU admission | 37.4 [1.2] | 37.4 [1.1] | 37.4 [1.4] |
SAP mmHg H1 | 117 [30] | 118 [26] | 113 [26] |
DAP mmHg H1 | 58 [11] | 58 [13] | 58 [9] |
MAP mmHg H1 | 75 [12.5] | 77 [15] | 71 [7] |
Heart rate (beat/min) H1 | 98 [19] | 94 [16] | 103 [23] |
Mechanical ventilation (n of patients) | 27 | 16 | 11 |
Creatinine before onset (μmol/L) | 267 [129] | 257 [84] | 293 [164] |
Diuresis < 100 ml/6 h before inclusion (no. patients) | 20 | 12 | 8 |
Hydrocortisone treatment (no. patients) | 17 | 9 | 8 |
Norepinephrine (no. patients) | 23 | 12 | 11 |
Dobutamine (no. patients) > 5 μg/kg/h | 5 | 2 | 3 |
Epinephrine (no. patients) | 3 | 2 | 1 |
Lactate (mmol/L) | 3.7 [3.6] | 4.1 [3.4] | 3.2 [2.3] |